NEW YORK, July 29, 2015 /PRNewswire/ --
Equity Research Institute has initiated coverage on the
following equities: J. C. Penney Company Inc. (NYSE: JCP), Macy's
Inc. (NYSE: M), Kohl's Corporation (NYSE: KSS), The TJX Companies
Inc. (NYSE: TJX), and Dillard's Inc. (NYSE: DDS). Free research
report on J. C. Penney can be
accessed at
https://www.EquityResearchInstitute.com/reports?keyword=JCP On
Tuesday, July 28, 2015, the NASDAQ
Composite ended at 5,089.21, up 0.98%, the Dow Jones Industrial
Average advanced 1.09%, to finish the day at 17,630.27, and the
S&P 500 closed at 2,093.25, up 1.24%. The gains were broad
based as all the sectors ended the session in positive. Register
for your complimentary reports at the links given below.
J. C. Penney Co. Inc.'s stock edged 0.49% lower, to close the
day at $8.20. The stock recorded a
trading volume of 9.92 million shares, below its three months
average volume of 12.03 million shares. Over the last one month and
over the past three months, J. C. Penney Co. Inc.'s shares have
fallen by 7.13% and 4.65%, respectively. However, the stock has
surged 26.54% since the start of this year. The company's shares
are trading 3.17% above their 200-day moving average. Additionally,
J. C. Penney Co. Inc. has a Relative Strength Index (RSI) of 38.27.
Sign up and read the free notes on JCP at:
https://www.EquityResearchInstitute.com/reports?keyword=JCP
On Tuesday, shares in Macy's Inc. recorded a trading volume of
5.92 million shares, higher than their three months average volume
of 5.10 million shares. The stock ended the day 1.53% lower at
$68.88. Shares of the company traded
at a PE ratio of 16.32. Although, Macy's Inc.'s stock has lost
1.39% in the last one month, it has advanced 5.23% in the previous
three months and 5.83% on YTD basis. The company is trading above
its 50-day and 200-day moving averages by 0.16% and 7.20%,
respectively. Furthermore, shares of Macy's Inc. have an RSI of
47.90. The complimentary notes on M can be downloaded in PDF format
at:
https://www.EquityResearchInstitute.com/reports?keyword=M
Kohl's Corp.'s stock edged 0.60% lower, to close Tuesday's
session at $61.41. The stock recorded
a trading volume of 1.61 million shares, below its three months
average volume of 3.09 million shares. Over the last one month and
the previous three months, Kohl's Corp.'s shares have lost 3.09%
and 15.56%, respectively. However, the stock has gained 1.95% on
YTD basis. The company is trading 3.50% and 4.60% below its 50-day
and 200-day moving averages, respectively. Furthermore, Kohl's
Corp.'s stock traded at a PE ratio of 14.25 and has an RSI of
38.63. Register for free on Equity Research Institute and access
the latest research on KSS at:
https://www.EquityResearchInstitute.com/reports?keyword=KSS
The TJX Cos. Inc.'s stock finished Tuesday's session 0.77%
higher at $67.86. A total of 1.68
million shares were traded, which was below its three months
average volume of 2.74 million shares. Over the last one month and
since the beginning of 2015, The TJX Cos. Inc.'s shares have fallen
by 0.24% and 0.48%, respectively. However, the stock has gained
4.86% in the previous three months. The company's shares are
trading above their 50-day and 200-day moving averages by 1.33% and
2.54%, respectively. The TJX Cos. Inc.'s stock traded at a PE ratio
of 21.21 and has an RSI of 52.20. The complete research on TJX is
available for free at:
https://www.EquityResearchInstitute.com/reports?keyword=TJX
On Tuesday, shares in Dillard's Inc. ended the session 0.20%
lower at $99.00. The stock reported a
trading volume of 0.47 million shares, below its three months
average volume of 0.56 million shares. Shares of the company traded
at a PE ratio of 12.48. Dillard's Inc.'s shares have declined 8.49%
in the last one month, 25.65% in the previous three months and
20.83% on YTD basis. The stock is trading 8.78% below its 50-day
moving average and 16.38% below its 200-day moving average.
Moreover, shares of Dillard's Inc. have an RSI of 28.70. Free
in-depth research on DDS is available at:
https://www.EquityResearchInstitute.com/reports?keyword=DDS
--
About Equity Research Institute:
Equity Research Institute ("ERI") produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. ERI has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ERI has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the "CFA®"),
provides necessary guidance in preparing the document templates.
The Reviewer has reviewed and revised the content, as necessary,
based on sound investment judgment and publicly available
information which is believed to be reliable. The Reviewer and the
CFA® have not performed any independent investigations or forensic
audits to validate the information herein. Unless otherwise noted,
any content outside of this document has no association with the
Author, the Reviewer, or the CFA® (collectively referred to as the
"Production Team") in any way. The Production Team is compensated
on a fixed monthly basis and do not hold any positions of interest
in any of the securities mentioned herein.
NO WARRANTY
ERI, the Author, the Reviewer and the CFA® (collectively
referred to as the "Publishers") are not responsible for any error
which may be occasioned at the time of printing of this document or
any error, mistake or shortcoming. No liability is accepted by the
Publishers whatsoever for any direct, indirect or consequential
loss arising from the use of this document. The Publishers
expressly disclaim any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance
placed on the information in this document. Additionally, the
Publishers do not (1) guarantee the accuracy, timeliness,
completeness or correct sequencing of the information, or (2)
warrant any results from use of the information. The included
information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ERI nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://www.equityresearchinstitute.com.
RESTRICTIONS
ERI is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia. Do not send email to
robottrap (at) equityresearchinstitute.com.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.equityresearchinstitute.com